| Prospective Quality Improvement Project for High-Risk Diabetes Patients (NCT06472609) | Taipei Medical University WanFang Hospital | 2021-07-29 |
| Performance Evaluation of the VIDAS TB-IGRA Assay. (NCT04048018) | BioMérieux | 2019-12-05 |
| Risk of SDRs Under 3HP and 1HP Regimen for LTBI (NCT04094012) | National Taiwan University Hospital | 2019-09-24 |
| Nurse-Led Community Health Worker Adherence Model in 3HP Delivery Among Homeless Adults at Risk for TB Infection and HIV (NCT03702049) | University of California, Irvine | 2019-01-24 |
| Latent Tuberculosis in Type 2 Diabetes (NCT06874725) | Taichung Veterans General Hospital | 2018-04-18 |
| Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection (NCT03312647) | Hanyang University | 2017-06-19 |
| Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment (NCT02810678) | McGill University | 2016-07-01 |
| VDOT for Monitoring Adherence to LTBI Treatment (NCT02641106) | University of California, San Diego | 2016-03-08 |
| Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection (NCT02225158) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-08-15 |
| Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan (NCT02208427) | National Taiwan University Hospital | 2014-08-01 |
| Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis (NCT01622140) | Centers for Disease Control and Prevention | 2012-10-01 |
| Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT (NCT01582711) | Centers for Disease Control and Prevention | 2012-09-01 |
| TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI Treatment (NCT01549457) | University of British Columbia | 2012-04-01 |
| "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients". (NCT01761201) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2012-01-01 |
| Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9) (NCT00170209) | McGill University | 2011-08-01 |
| QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study. (NCT01223534) | Hospital Universitari de Bellvitge | 2010-07-01 |
| Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection (NCT01136161) | Archivel Farma S.L. | 2010-06-01 |
| Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients (NCT01608685) | Ligue Pulmonaire Genevoise | 2010-01-01 |
| Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness (NCT00931736) | McGill University | 2009-08-01 |
| Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent Tuberculosis (NCT00558480) | Medical Research Council Unit, The Gambia | 2009-07-01 |
| Demonstration of the Dynamic Hypothesis of Latent Tuberculosis Infection (NCT00905970) | Germans Trias i Pujol Hospital | 2009-05-01 |
| Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits (NCT00804713) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2009-03-01 |
| Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients (NCT00805272) | Assistance Publique - Hôpitaux de Paris | 2009-02-01 |
| Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection (NCT00692809) | Ministry of Science and Technology, India | 2008-07-01 |
| Diagnosis of Tuberculosis Infection in HIV Co-infected Children (NCT00541294) | Case Western Reserve University | 2008-01-15 |
| Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay (NCT01007396) | Samsung Medical Center | 2008-01-01 |
| Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons (NCT00463086) | University of Cape Town | 2007-11-01 |
| Screening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness Analysis (NCT00449345) | Assuta Hospital Systems | 2007-05-01 |
| Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers (NCT00546273) | Germans Trias i Pujol Hospital | 2007-04-01 |
| Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area (NCT00557765) | University Hospital, Geneva | 2004-10-01 |